Hospital News and Research

RSS

Shire receives European marketing approval for VPRIV therapy to treat type 1 Gaucher disease

Shire, the global specialty biopharmaceutical company, announced today that the European Commission has granted marketing authorisation for VPRIV(R) (velaglucerase alfa), a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of type 1 Gaucher disease.

27 Aug 2010

JVIR supplement to review thermal ablation usage in treating cancer

The unprecedented growth and promise of using thermal ablation to target and kill cancer is the subject of the Journal of Vascular and Interventional Radiology's August supplement, "Thermal Ablation 2010 At the Crossroads of Past Success, Current Goals and Future Technology."

27 Aug 2010

Premier healthcare alliance labor management program helps hospitals save over $120 million

During a period of economic uncertainty, 150 hospitals and healthcare systems saved more than $120 million in labor and supply costs over the past year by participating in LaborConnect®, a Premier healthcare alliance labor management program.

27 Aug 2010

InfoLogix announces strategic plans for 2010 second half

InfoLogix, Inc.,a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced its strategic plans for the second half of 2010.

27 Aug 2010

FDA clears SonoSite's LumenVu Catheter Guidance System

SonoSite, Inc., the world leader and specialist in bedside and point-of-care ultrasound, announced today that it received FDA clearance for its innovative LumenVu® Catheter Guidance System. Designed to aid in the placement of peripherally inserted central catheters (PICC), the proprietary LumenVu System combines near-infrared technology with a revolutionary fiber optic stylet, which replaces a traditional guide wire, to allow visualization and real-time tracking of a catheter tip as it advances through a vein.

27 Aug 2010

Experimental drug PLX4032 holds promise against cancers with faulty BRAF gene

An experimental drug designed to treat cancers with a particular genetic fault has shown promising results in a small clinical trial.

27 Aug 2010

Nationwide Children's Hospital designated as Wellstone Muscular Dystrophy Cooperative Research Center

A $7 million grant from the National Institutes of Health (NIH) will help researchers at Nationwide Children's Hospital translate new scientific findings and technological developments into novel treatments for the muscular dystrophies. The grant designates Nationwide Children's Hospital as a Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, one of three national award recipients in 2010.

27 Aug 2010

Researchers identify molecule to slow down dysfunctional immune response in hemorrhagic shock

Researchers have isolated a molecule, small enough to be used as a drug, that can shut down a dysfunctional immune response that causes deadly hemorrhagic shock, results in delayed death of heart attack patients, promotes rejection of transplanted organs and destroys joints in patients with rheumatoid arthritis, according to a paper published in Molecular Immunology.

27 Aug 2010

5 years after Katrina, Gulf area still struggles with access to quality health care, mental health counseling

"Finding quality health care continues to be a challenge in the New Orleans area. Five years ago, Hurricane Katrina flooded area hospitals, destroyed buildings and scattered patients. The health care industry has been slow to recover and in some cases, facilities still haven't opened. …

27 Aug 2010

Disulfiram drug effective in treating cocaine addiction: Research

Doctors have used the drug disulfiram to help patients stay sober for several decades. It interferes with the body's ability to metabolize alcohol, giving a fierce hangover to someone who consumes even a small amount of alcohol.More recently, disulfiram was shown to be effective in treating cocaine addiction as well, even though alcohol and cocaine affect the nervous system in different ways.

27 Aug 2010

At least 3.5M Pakistanis have no access to clean water, raising risk for waterborne diseases

UNICEF estimates that about 3.5 million Pakistanis only have access to contaminated water, the U.N. Office for the Coordination of Humanitarian Affairs (OCHA) said on Wednesday in a statement, Bloomberg Businessweek reports. Approximately 2.5 million flood survivors now have access clean water (Gale, 8/26).

27 Aug 2010

$1.3 billion in Detroit hospital upgrades could drive up health costs

A new report suggests that $1.3 billion in upgrades to hospitals in Detroit could drive up health care costs. The funding "may give a boost to Metro Detroit's languishing economy, but could also saddle residents with higher medical costs, according to an industry report funded by the United Auto Workers and Detroit's Big Three automakers," The Detroit News reports.

27 Aug 2010

BrainScope technology specifically identifies triage for Computed Tomography to ED patients

BrainScope Company, Inc. today announced the publication of clinical research findings from a study in patients presenting to the Emergency Department (ED) following a closed head injury.

27 Aug 2010

Bioheart reports promising result for congestive heart failure treatment with stem cell therapy

Bioheart, Inc., announces that the treatments and 3 month follow up with stem cell therapy on the first two congestive heart failure patients has been performed successfully at Hospital Angeles Tijuana through its Center of Excellence, Regenerative Medicine Institute of Tijuana, Mexico.

27 Aug 2010

Hemoglobin variability does not increase mortality in European hemodialysis patients: Study

Fluctuations in blood composition that often arise from commonly used therapies among kidney disease patients are not an independent predictor of adverse outcomes for European hemodialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results suggest that although hemoglobin variability is common in kidney disease patients, it does not appear to increase their likelihood of dying early.

27 Aug 2010

Study on impact of harmful de novo gene mutations on autism, schizophrenia

An international study led by University of Montreal scientists suggests family history may not be a good predictor of the presence of mutations predisposing to autism or schizophrenia. The findings show how new or de novo gene mutations alterations of the cell's DNA play a role in these devastating conditions.

27 Aug 2010

U-M researchers explore prevention measures, treatments for C. difficile infection

Clostridium difficile, a wily, familiar bacterium, causes a growing number of serious infections in U.S. hospitals and nursing homes. With a $7.5 million, five-year award from the National Institutes of Health, University of Michigan researchers plan to discover what factors in the microbe and in patients make C. difficile a formidable, costly problem.

27 Aug 2010

Study finds PCV7 vaccine reduces bacterial pneumonia infection in children

The number of children admitted to English hospitals with bacterial pneumonia decreased by a fifth in the two years following the introduction of a vaccine to combat the disease, according to a new study published today in the journal Thorax.

27 Aug 2010

National Kickoff Classic partners with Close the Gap campaign to raise heart disease risk factor awareness

Boston Scientific today announced that its Close the Gap campaign is partnering with the Kirk Herbstreit National Kickoff Classic to raise awareness of heart disease risk factors for women and minorities.

26 Aug 2010

Aethlon Medical receives approval for Chronic HCV Infection treatment

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the Medanta Independent Ethics Committee (MIEC) at Medanta, The Medicity Institute (Medicity) has approved a treatment program entitled "Use of the Aethlon Hemopurifier in Treating Chronic HCV Infection in Combination with Standard of Care (SOC) Drug Therapy."

26 Aug 2010

Hospital News and Research

Shire receives European marketing approval for VPRIV therapy to treat type 1 Gaucher disease

JVIR supplement to review thermal ablation usage in treating cancer

Premier healthcare alliance labor management program helps hospitals save over $120 million

InfoLogix announces strategic plans for 2010 second half

FDA clears SonoSite's LumenVu Catheter Guidance System

Experimental drug PLX4032 holds promise against cancers with faulty BRAF gene

Nationwide Children's Hospital designated as Wellstone Muscular Dystrophy Cooperative Research Center

Researchers identify molecule to slow down dysfunctional immune response in hemorrhagic shock

5 years after Katrina, Gulf area still struggles with access to quality health care, mental health counseling

Disulfiram drug effective in treating cocaine addiction: Research

At least 3.5M Pakistanis have no access to clean water, raising risk for waterborne diseases

$1.3 billion in Detroit hospital upgrades could drive up health costs

BrainScope technology specifically identifies triage for Computed Tomography to ED patients

Bioheart reports promising result for congestive heart failure treatment with stem cell therapy

Hemoglobin variability does not increase mortality in European hemodialysis patients: Study

Study on impact of harmful de novo gene mutations on autism, schizophrenia

U-M researchers explore prevention measures, treatments for C. difficile infection

Study finds PCV7 vaccine reduces bacterial pneumonia infection in children

National Kickoff Classic partners with Close the Gap campaign to raise heart disease risk factor awareness

Aethlon Medical receives approval for Chronic HCV Infection treatment

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News